Search tips
Search criteria 


Logo of jathtrainLink to Publisher's site
J Athl Train. 1998 Jul-Sep; 33(3): 259–263.
PMCID: PMC1320434

Pharmacologic Considerations in the Treatment of Injured Athletes with Nonsteroidal Anti-Inflammatory Drugs



Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to relieve discomfort and enhance the rate of recovery from athletic injuries. A clear understanding of general pharmacologic principles may help the health care professional to optimize therapeutic outcomes and minimize undesirable effects. Such principles include onset and duration of drug action, potency, half-life, steady state, and the impact of exercise and disease on drug absorption, metabolism, and excretion.

Data Sources:

I searched the MEDLINE and CINAHL data- bases from 1983 to 1997 for the terms “anti-inflammatory drugs,” “NSAIDs,” “sports medicine,” “injury,” and “rehabilitation.”

Data Synthesis:

The NSAIDs exert their mechanism of action primarily through the inhibition of arachidonic acid metabolism. A basic understanding of this mechanism on the part of the health care professional facilitates an understanding of potential side effects and drug interactions, especially those related to increased blood clotting time, diminished kidney function, and occurrence of gastrointestinal discomfort. The effectiveness of NSAIDs in increasing the rate of healing and relieving pain and inflammation can be affected by variables such as the extent of injury, drug dosing, duration of therapy, and the specific drug used.


Some general therapeutic concepts that should be considered before using NSAIDs include the following: (1) Only 1 of these agents should be used at a time in a patient. (2) They should preferably be given with food. (3) Specific outcomes should be delineated. (4) Each patient's physical condition and medical history should be considered before NSAIDs are instituted.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (984K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs--differences and similarities. N Engl J Med. 1991 Jun 13;324(24):1716–1725. [PubMed]
  • Small RE, Van Vranken SM. Drug-NSAID interactions. Am Pharm. 1995 Mar;NS35(3):53–55. [PubMed]
  • Furst DE. Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1994 Jan;37(1):1–9. [PubMed]
  • Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol. 1992 Aug;263(2 Pt 2):F181–F191. [PubMed]
  • Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta. 1991 Apr 24;1083(1):1–17. [PubMed]
  • Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987 Sep 4;237(4819):1171–1176. [PubMed]
  • O'Neill GP, Mancini JA, Kargman S, Yergey J, Kwan MY, Falgueyret JP, Abramovitz M, Kennedy BP, Ouellet M, Cromlish W, et al. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol. 1994 Feb;45(2):245–254. [PubMed]
  • Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 1994 May 6;269(18):13207–13215. [PubMed]
  • Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ., 2nd A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9383–9387. [PubMed]
  • Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978 Sep;30(3):293–331. [PubMed]
  • Baumert PW., Jr Acute inflammation after injury. Quick control speeds rehabilitation. Postgrad Med. 1995 Feb;97(2):35–passim. [PubMed]
  • Leadbetter WB. Anti-inflammatory therapy in sports injury. The role of nonsteroidal drugs and corticosteroid injection. Clin Sports Med. 1995 Apr;14(2):353–410. [PubMed]
  • Weiler JM. Medical modifiers of sports injury. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) in sports soft-tissue injury. Clin Sports Med. 1992 Jul;11(3):625–644. [PubMed]
  • Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription dosages. J Pharm Pharmacol. 1997 Apr;49(4):345–376. [PubMed]

Articles from Journal of Athletic Training are provided here courtesy of National Athletic Trainers Association